ABVC BioPharma, Inc.: 10-Q filed 2015-04-16
What ABVC BioPharma, Inc. reported in its quarterly report filed 2015-04-16 (fiscal Q2 2013): 25 published measures, 68 facts as tagged in accession 0001557234-15-000086.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-04-16
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001557234-15-000086 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ABVC BioPharma, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 251,342 | USD | |
| At 2012-09-30 | 302,308 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -1,840,916 | USD | |
| At 2012-09-30 | -1,643,778 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 788 | USD | |
| At 2012-09-30 | 13,386 | USD | |
| At 2012-03-31 | 0 | USD | |
| At 2011-09-30 | 71,784 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -104,276 | USD | 90 |
| 2012-10-01 to 2013-03-31 | -190,442 | USD | 182 |
| 2012-01-01 to 2012-03-31 | -342,840 | USD | 91 |
| 2011-10-01 to 2012-03-31 | -619,980 | USD | 183 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-03-31 | -37,598 | USD | 182 |
| 2011-10-01 to 2012-03-31 | -582,315 | USD | 183 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-03-31 | 0 | USD | 182 |
| 2011-10-01 to 2012-03-31 | 350 | USD | 183 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 761 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 7,787 | USD | 182 |
| 2012-01-01 to 2012-03-31 | 3,665 | USD | 91 |
| 2011-10-01 to 2012-03-31 | 5,714 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-03-31 | 25,000 | USD | 182 |
| 2011-10-01 to 2012-03-31 | 528,185 | USD | 183 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-03-31 | 0 | USD | 182 |
| 2011-10-01 to 2012-03-31 | -17,654 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | -30,511,000 | USD | |
| At 2012-09-30 | -30,313,862 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 67,637 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 0 | USD | 182 |
| 2012-01-01 to 2012-03-31 | 0 | USD | 91 |
| 2011-10-01 to 2012-03-31 | 0 | USD | 183 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 40,427 | USD | |
| At 2012-09-30 | 46,783 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -20,452 | USD | 90 |
| 2012-10-01 to 2013-03-31 | -157,886 | USD | 182 |
| 2012-01-01 to 2012-03-31 | -330,553 | USD | 91 |
| 2011-10-01 to 2012-03-31 | -789,531 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 13,276 | USD | |
| At 2012-09-30 | 48,336 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 16,187 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 32,556 | USD | 182 |
| 2012-01-01 to 2012-03-31 | 12,287 | USD | 91 |
| 2011-10-01 to 2012-03-31 | 59,251 | USD | 183 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 2,092,258 | USD | |
| At 2012-09-30 | 1,946,086 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 197,639 | USD | |
| At 2012-09-30 | 207,189 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 1,238 | USD | |
| At 2012-09-30 | 0 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | 21,213 | USD | 90 |
| 2012-10-01 to 2013-03-31 | 165,673 | USD | 182 |
| 2012-01-01 to 2012-03-31 | 334,218 | USD | 91 |
| 2011-10-01 to 2012-03-31 | 795,245 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 54,593,032 | shares | |
| At 2012-09-30 | 14,158,506 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-03-31 | 28,615,490 | USD | |
| At 2012-09-30 | 28,615,490 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -107,624 | USD | 90 |
| 2012-10-01 to 2013-03-31 | -197,138 | USD | 182 |
| 2012-01-01 to 2012-03-31 | -529,737 | USD | 91 |
| 2011-10-01 to 2012-03-31 | -998,669 | USD | 183 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-03-31 | -16,187 | USD | 90 |
| 2012-10-01 to 2013-03-31 | -32,556 | USD | 182 |
| 2012-01-01 to 2012-03-31 | -12,287 | USD | 91 |
| 2011-10-01 to 2012-03-31 | 169,551 | USD | 183 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-03-31 | 1,238 | USD | 182 |
| 2011-10-01 to 2012-03-31 | 3,312 | USD | 183 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-10-01 to 2013-03-31 | 81,920 | USD | 182 |
| 2011-10-01 to 2012-03-31 | -298 | USD | 183 |
Inspect the source
- Entity
- ABVC BioPharma, Inc. / CIK 0001173313
- Captured
- 2026-09-19T11:16:49.109Z
- SEC response SHA-256
a42942c118304cb578665c27ca73d827a17f370dd57a31742c919c9b41b25c34
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001173313.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))